{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:16:44Z","timestamp":1777655804711,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.crad.2018.09.015","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T19:22:49Z","timestamp":1540495369000},"page":"81.e9-81.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis"],"prefix":"10.1016","volume":"74","author":[{"given":"B.","family":"Sgard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-Y.","family":"Brillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bouvry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Djelbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Meune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Valeyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Soussan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.crad.2018.09.015_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11)","volume":"63","author":"Roberts","year":"1977","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.crad.2018.09.015_bib2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.crad.2018.09.015_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","article-title":"Clinicopathological study of fatal myocardial sarcoidosis","volume":"278","author":"Matsui","year":"1976","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.crad.2018.09.015_bib4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1055\/s-0030-1262211","article-title":"Cardiac sarcoidosis","volume":"31","author":"Nunes","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.crad.2018.09.015_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.revmed.2016.03.003","article-title":"Cardiac sarcoidosis: diagnosis and therapeutic challenges","volume":"38","author":"Cohen Aubart","year":"2017","journal-title":"Rev Med Interne"},{"issue":"33","key":"10.1016\/j.crad.2018.09.015_bib6","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.crad.2018.09.015_bib7","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.hrthm.2007.06.006","article-title":"Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis","volume":"4","author":"Banba","year":"2007","journal-title":"Heart Rhythm Off J Heart Rhythm Soc"},{"issue":"3","key":"10.1016\/j.crad.2018.09.015_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCEP.110.959254","article-title":"Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults","volume":"4","author":"Kandolin","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"21","key":"10.1016\/j.crad.2018.09.015_bib9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the heart rhythm society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.crad.2018.09.015_bib10","first-page":"89","article-title":"Diagnostic standard and guidelines for sarcoidosis","volume":"27","year":"2007","journal-title":"Jpn J Sarcoidosis Granulomatous Disord"},{"issue":"2","key":"10.1016\/j.crad.2018.09.015_bib11","first-page":"241","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"2","key":"10.1016\/j.crad.2018.09.015_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00059-007-2972-5","article-title":"Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR)","volume":"32","author":"V\u00f6hringer","year":"2007","journal-title":"Herz"},{"issue":"12","key":"10.1016\/j.crad.2018.09.015_bib13","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis","volume":"10","author":"Kouranos","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.crad.2018.09.015_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijcard.2017.03.033","article-title":"Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging","volume":"241","author":"Bravo","year":"2017","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.crad.2018.09.015_bib15","first-page":"1030","article-title":"Identification of cardiac sarcoidosis with (13)N-NH(3)\/(18)F-FDG PET","volume":"44","author":"Yamagishi","year":"2003","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1016\/j.crad.2018.09.015_bib16","author":"Slart","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.crad.2018.09.015_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12350-012-9653-3","article-title":"Clinical value of a high-fat and low-carbohydrate diet before FDG-PET\/CT for evaluation of patients with suspected cardiac sarcoidosis","volume":"20","author":"Soussan","year":"2013","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.crad.2018.09.015_bib18","first-page":"99","article-title":"Advanced imaging of cardiac sarcoidosis","volume":"55","author":"Schatka","year":"2014","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"18","key":"10.1016\/j.crad.2018.09.015_bib19","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2169\/internalmedicine.53.2491","article-title":"Visual findings of (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography in patients with cardiac sarcoidosis","volume":"53","author":"Ito","year":"2014","journal-title":"Intern Med Tokyo Jpn"},{"key":"10.1016\/j.crad.2018.09.015_bib20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijcard.2016.11.142","article-title":"Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis","volume":"228","author":"Shelke","year":"2017","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.crad.2018.09.015_bib21","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.ejrad.2013.06.005","article-title":"T2-weighted imaging of the heart\u2014a pictorial review","volume":"82","author":"Mirakhur","year":"2013","journal-title":"Eur J Radiol"},{"issue":"5","key":"10.1016\/j.crad.2018.09.015_bib22","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.crad.2018.09.015_bib23","first-page":"1594","article-title":"Mapping the future of cardiac MR imaging: case-based review of T1 and T2 mapping techniques","volume":"34","author":"Hamlin","year":"2014","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"key":"10.1016\/j.crad.2018.09.015_bib24","article-title":"Inter- and Intra- observer agreement of FDG-PET\/CT image interpretation in patients referred for assessment of cardiac sarcoidosis","author":"Ohira","year":"2017","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"12","key":"10.1016\/j.crad.2018.09.015_bib25","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.hrthm.2015.06.032","article-title":"Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complete heart block","volume":"12","author":"Orii","year":"2015","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.crad.2018.09.015_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00259-015-3181-8","article-title":"Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis","volume":"43","author":"Ohira","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.crad.2018.09.015_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","volume":"23","author":"Manabe","year":"2016","journal-title":"J Nucl Cardiol"},{"issue":"22","key":"10.1016\/j.crad.2018.09.015_bib28","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.1161\/CIRCULATIONAHA.112.001217","article-title":"Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography\u2013magnetic resonance imaging for the diagnosis of cardiac disease","volume":"127","author":"White","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.crad.2018.09.015_bib29","article-title":"Feasibility of FDG-PET in myocarditis: comparison to CMR using integrated PET\/MRI","author":"Nensa","year":"2016","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"10.1016\/j.crad.2018.09.015_bib30","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.crad.2018.09.015_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00259-015-3181-8","article-title":"Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis","volume":"43","author":"Ohira","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.crad.2018.09.015_bib32","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s12350-016-0653-6","article-title":"Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: a case series","volume":"25","author":"Zandieh","year":"2018","journal-title":"J Nucl Cardiol"},{"issue":"7","key":"10.1016\/j.crad.2018.09.015_bib33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid","volume":"19","author":"Wicks","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.crad.2018.09.015_bib34","doi-asserted-by":"crossref","first-page":"e007030","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.crad.2018.09.015_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis","volume":"11","author":"Dweck","year":"2018","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000992601830552X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000992601830552X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:39:07Z","timestamp":1757867947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000992601830552X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S000992601830552X"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2018.09.015","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2018.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}]}}